Celldex Therapeutics is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company has four drug candidates in clinical development, including CDX-1140, an agonist human monoclonal antibody targeted to CD40, a key activator of immune response; CDX-3379, a human monoclonal antibody designed to block the activity of ErbB3; varlilumab, an immune modulating antibody targeting CD27 designed to improve a patient's immune response; and CDX-301, a dendritic cell growth factor.

comScore is a global information and analytics company that measures consumer audiences and advertising across media platforms. The company creates its products using a global data platform that combines information about content and advertising consumption on digital platforms (smartphones, tablets and computers), television and movie screens with demographics and other descriptive information. The company has developed proprietary data science that enables measurement of person-level and household-level audiences, removing duplicated viewing across devices and over time. The company provides audience ratings, advertising verification, and granular consumer segments that describe consumers.

Granite Point Mortgage Trust operates as a real estate investment trust. The company focuses primarily on directly originating, investing in and managing senior floating-rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company is externally managed by Pine River Capital Management L.P. The company's primary target investments are directly originated floating-rate performing senior commercial real estate loans. The company provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancings and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.

Nicholas Financial is a holding company. Through its subsidiary, Nicholas Financial, Inc., the company is engaged primarily in acquiring and servicing automobile finance installment contracts (Contracts) for purchases of used and new automobiles and light trucks. In addition, the company also originates direct consumer loans (Direct Loans) and sells consumer-finance related products. For Automobile Finance Business - Contracts, the company is engaged in the business of providing financing programs, on behalf of purchasers of used cars and light trucks. For Contract Procurement, the Contracts purchased by the company is for used vehicles. For Direct Loans, the loans originated directly between the company and the consumer.

Old Second Bancorp is a bank holding company. Through its subsidiaries, the company conducts community banking and trust business. The company is a banking business providing a range of deposit products, trust and wealth management services, and lending services; commercial, industrial, consumer and real estate lending, safe deposit operations, and additional services for individual customers. The company's lending activities include making commercial and consumer loans, mainly on a secured basis. The company provides various wealth management, investment, agency, and custodial services for individual, corporate, and not-for-profit clients. The company also originates residential mortgages, providing a range of mortgage products.

Tivity Health engages in fitness programs. Through its three programs, SilverSneakers? senior fitness, Prime? fitness and WholeHealth Living?, the company is focused on health and vitality in aging populations. The SilverSneakers senior fitness program is provided to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans. The company provides Prime fitness, a fitness facility access program, via commercial health plans and employers. The company's network of fitness centers delivers both SilverSneakers and Prime fitness. Via its WholeHealth Living program, which the company sells to health plans, the company provides services related to complementary, alternative, and physical medicine.

Ultralife provides products and services ranging from power solutions to communications and electronics systems. The company has two operating segments: Battery and Energy Products, which includes lithium nine-volt, cylindrical, thin cell and other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems and accessories; and Communications Systems, which includes radio frequency amplifiers, power supplies, cable and connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, integrated communication systems for fixed or vehicle applications and communications and electronics systems design.

Zogenix is a pharmaceutical company developing and commercializing transformative central nervous system (CNS) therapies for people living with CNS disorders and medical conditions. The company is focused on developing and commercializing CNS therapies to address rare, or orphan childhood-onset epilepsy disorders. The company owns and controls worldwide development and commercialization rights to Fintepla/ZX008, its primary product candidate. Fintepla is low-dose fenfluramine under development for the treatment of seizures associated with two rare and catastrophic forms of childhood-onset epilepsy: Dravet syndrome and Lennox-Gastaut syndrome.